Rat LEP(Leptin) ELISA Kit
中文名称:大鼠瘦素(LEP)酶联免疫吸附测定试剂盒
Price:
- 反应性: Rat
- 检测范围: 0.16-10 ng/mL
- 灵敏度: 0.1 ng/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗大鼠LEP抗体包被于酶标板上,实验时样品(或标准品)中的大鼠LEP会与包被抗体结合。后依次加入生物素化的抗大鼠LEP抗体和辣根过氧化物酶标记的亲和素,抗大鼠LEP抗体与结合在包被抗体上的大鼠LEP结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,LEP浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中LEP的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96 T
/ 48 T
/ 96 T * 5
|
反应时间 | 3.5h |
反应性 | Rat |
检测方法 | 比色法;ELISA;夹心法 |
检测范围 | 0.16-10 ng/mL |
灵敏度 | 0.1 ng/mL |
样本体积 | 100μL |
样本类型 | 血清、血浆、细胞上清、细胞提取液体、组织匀浆等其他生物体液 |
特异性 | 可检测样本中的大鼠LEP,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃/-20℃ |
数据处理 |
-
Nicotine-mediated upregulation of microRNA-141 expression determines adipokine-intervened insulin resistance
IF: 3.292 -
Chronic exposure of bisphenol A impairs carbohydrate and lipid metabolism by altering corresponding enzymatic and metabolic pathways
IF: 3.292 -
Perinatal exposure to germinated brown rice and its gamma amino-butyric acid-rich extract prevents high fat diet-induced insulin resistance in first generation rat offspring
IF: 3.226Journal:Food & Nutrition Research -
Edible bird’s nest attenuates procoagulation effects of high-fat diet in rats
IF: 3.028Journal:Drug Design Development and Therapy -
Curcumin ameliorates high‑fat diet‑induced spermatogenesis dysfunction
IF: 2.952Journal:Molecular Medicine Reports -
Orlistat attenuates obesity‐induced decline in steroidogenesis and spermatogenesis by up‐regulating steroidogenic genes
IF: 2.86Journal:Andrology -
Treadmill running induces remodeling of the infrapatellar fat pad in an intensity-dependent manner
IF: 2.359 -
Investigation of therapeutic potential of three endemic Cirsium species for global health problem obesity
IF: 2.315Journal:SOUTH AFRICAN JOURNAL OF BOTANY -
In utero exposure to germinated brown rice and its oryzanol-rich extract attenuated high fat diet-induced insulin resistance in F1 generation of rats
IF: 2.288Journal:BMC Complementary and Alternative Medicine -
Combined treatment with interleukin-1 and tumor necrosis factor-alpha antagonists improve type 2 diabetes in rats
IF: 2.21Journal:CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY